Head-to-head · Cost-Efficiency Index
Spry vs Go Vida Plena
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Spry
Shoppers who want compounded GLP-1 bundled with anti-aging peptides from one named founding team.
Visit SpryGo Vida Plena
Cost-first shoppers who want spanish-speaking patients wanting GLP-1 access with culturally-tailored, Spanish-first support.
Visit Go Vida PlenaThe verdict
Spry takes it, leading the Cost-Efficiency Index 67 to 66. Spry is a weight-loss and anti-aging telehealth brand, founded by Gabriel Mullins, Sara Yoder, and Tyler Bowman. Go Vida Plena still earns a C — Cost-first shoppers who want spanish-speaking patients wanting GLP-1 access with culturally-tailored, Spanish-first support.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Spry.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Spry | Go Vida Plena |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 66/100 |
| Semaglutide / mo | $199/mo (all doses, compounded) | $179/mo (annual plan, compounded) |
| Tirzepatide / mo | $299/mo (all doses, compounded) | $269/mo (annual plan, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,148 |
| Tirzepatide / yr (modeled) | $3,588 | $3,228 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #140 | #147 |
Spry
67/100Where the value is
- Real, named founding team with individual bios — confirmed live on the About page
- Pricing shown directly on the homepage and product pages, no sign-up wall required
- Explicitly describes its GLP-1s as compounded rather than leaving formulation ambiguous
The tradeoffs
- No dose-tier price breakdown is published for either drug
- No compounding pharmacy is named anywhere on the pages checked
Go Vida Plena
66/100Where the value is
- Genuinely bilingual, Spanish-first platform serving an underserved market segment
- Offers both injectable and oral GLP-1 formulations
- Explicit, plain-language disclosure that compounded drugs are not FDA-approved
The tradeoffs
- Lowest advertised prices ($179/$269) require an annual plan commitment, not simple month-to-month billing
- Per-day price framing ('~$6/day') is used on the homepage, a common technique to understate the real monthly cost
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.